Reproductive Health
News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays
A ratio of the two biomarkers detected by the 30-minute clinical chemistry assays can be used for prognosis and treatment of preeclampsia.
Labcorp Ordered to Pay Ravgen Another $100M in Patent Lawsuit
Following its $272.5 million jury award last year, Ravgen secured enhanced damages for Labcorp's past violations of its prenatal testing patents.
Myriad Genetics Revenues Grow 10 Percent, Beating Wall Street Estimate
Strong test volume growth drove the revenue increase, while net loss more than doubled year over year.
Myriad Genetics Revenues Grow 10 Percent, Beating Wall Street Estimate
Strong test volume growth drove the revenue increase, while net loss more than doubled year over year.
The five-year, EU-funded project, called MensEndoDiag, will explore the use of menstrual blood as a sample type.